GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut. Show more
Location: North Tower, Stamford, CT, 06902, United States | Website: https://www.genedx.com | Industry: Diagnostics & Research | Sector: Healthcare
Market Cap
3.998B
52 Wk Range
$55.17 - $146.00
Previous Close
$138.30
Open
$134.91
Volume
428,865
Day Range
$134.00 - $141.92
Enterprise Value
3.351B
Cash
155.1M
Avg Qtr Burn
N/A
Insider Ownership
12.26%
Institutional Own.
-
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
